Lexaria Bioscience Corp.

LEXX

$13.12

+6.49%+$0.80

High—

Low—

52W High-43.6%

Rel. vol—

Interval

Range2.4h

Volume—SMA5SMA10

—

AI analysis

Lexaria Bioscience Corp. is showing mixed intraday momentum with consolidation near key moving averages and heightened sensitivity to liquidity shifts.

Upside confirmation strengthens on sustained reclaim above short-term trend anchors.
Breakdown risk rises if support fails with accelerating sell volume.
Relative strength versus sector peers remains neutral-to-slightly positive.

Latest indicator snapshot

Live technical and fundamental context, tuned for quick reads.

SMA5

$12.37

5-period simple moving average

SMA10

$12.36

10-period simple moving average

SMA20

$12.36

20-period simple moving average

SMA50

$12.56

50-period simple moving average

EMA5

$12.35

5-period exponential moving average

EMA10

$12.36

10-period exponential moving average

EMA20

$12.39

20-period exponential moving average

DEMA20

$12.30

Double exponential moving average

Fibonacci

Retracement

Retracement levels

VWAP

$13.22

Volume weighted average price

MACD

-0.059

Signal -0.076

RSI(14)

51.6

Relative strength oscillator

OBV

-1.37K

On-balance volume

StochRSI

51.6 / 51.6

Fast oscillator pair

BBands Low

$12.20

Lower band

BBands Mid

$12.36

Middle band

BBands High

$12.52

Upper band

Market Cap

21.68M

Company size

P/E Ratio

0.00

Valuation multiple

EV / EBITDA

-7.22

Enterprise value multiple

ROE

-162.8%

Return on equity

ROA

-81.3%

Return on assets

Operating Margin

-3863.0%

Operating efficiency

Net Margin

0.0%

Bottom-line profitability

Current Ratio

—

Short-term liquidity

Debt / Equity

—

Balance-sheet leverage

Dividend Yield

0.0%

Income yield

FCF Yield

—

Free cash flow yield

Beta

0.34

Market sensitivity

52W High

$23.25

52-week peak

52W Low

$4.21

52-week trough

Supply Chain of LEXX

Upstream / Downstream / Proxies

Upstream

InClin, Inc.Unnamed CRO (GLP-1 Studies)BevNologyThird-Party Material/API Suppliers (Unnamed)Third-Party Regulatory Affairs Consultant (Unnamed)Standard Lab Equipment Suppliers (Unnamed)

Downstream

Altria Group, Inc.NYSE:MOPharmaCO (Anonymous Global Pharmaceutical Company)UnconfirmedSulfoSyn LimitedPremier Wellness Science Co., Ltd. (subsidiary of Premier Anti-Aging Co., Ltd.)TYO:4934AnodGen BioceuticalsBevNologyHill Street Beverage Company (now Hill Inc.)TSXV:HILL

Proxies

Catalent, Inc.NYSE:CTLTLonza Group AGSWX:LONNEnteris BioPharma (wholly owned by Spruce Biosciences)UnconfirmedRani Therapeutics Holdings, Inc.NASDAQ:RANI

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer